Your browser doesn't support javascript.
loading
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors.
Minari, Roberta; Bonatti, Francesco; Mazzaschi, Giulia; Dodi, Alessandra; Facchinetti, Francesco; Gelsomino, Francesco; Cinquegrani, Gloria; Squadrilli, Anna; Bordi, Paola; Buti, Sebastiano; Bersanelli, Melissa; Leonetti, Alessandro; Cosenza, Agnese; Ferri, Leonarda; Rapacchi, Elena; Quaini, Federico; Ardizzoni, Andrea; Tiseo, Marcello.
Afiliação
  • Minari R; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Bonatti F; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Mazzaschi G; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Dodi A; Department of Medicine & Surgery, University of Parma.
  • Facchinetti F; Department of Medicine & Surgery, University of Parma.
  • Gelsomino F; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Cinquegrani G; Université Paris-Saclay, Institut Gustave Roussy, Inserm, Biomarqueurs Prédictifs et Nouvelles Stratégies Thérapeutiques en Oncologie, Villejuif, France.
  • Squadrilli A; Medical Oncology, AOU Policlinico S. Orsola-Malpighi, Bologna, Italy.
  • Bordi P; Department of Medicine & Surgery, University of Parma.
  • Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Bersanelli M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Leonetti A; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Cosenza A; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Ferri L; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Rapacchi E; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Quaini F; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Ardizzoni A; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Tiseo M; Department of Medicine & Surgery, University of Parma.
Tumori ; 108(1): 47-55, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34002648
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antígeno B7-H1 / Antígeno CTLA-4 / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Antígeno B7-H1 / Antígeno CTLA-4 / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article